PR Newswire
RADNOR, Pa., Nov. 7, 2019
RADNOR, Pa., Nov. 7, 2019 /PRNewswire/ -- Safeguard Scientifics, Inc. (NYSE: SFE) ("Safeguard" or the "Company") today announced financial results. For the three months ended September 30, 2019, Safeguard's net loss was $2.5 million, or $0.12 per share on a basic and fully diluted basis, as compared with net income of $32.1 million or $1.56 per share, for the same period in 2018. For the nine months ended September 30, 2019, Safeguard's net income was $55.3 million, or $2.68 per share on a basic and fully diluted basis, as compared with a net income of $1.0 million or $0.05 per share for the same period in 2018.
On November 7, 2019, the Safeguard Board of Directors declared a special cash dividend of $1.00 per share, payable on December 30, 2019 to shareholders of record as of the close of business on December 23, 2019 (the "Record Date"). The ex-dividend date will be the trading day immediately prior to the Record Date.
"This dividend demonstrates our commitment to return value to our shareholders. And, we remain committed to continuing to reward our shareholders by maximizing the overall value of our partner company holdings and by returning that value to our shareholders as quickly and tax efficiently as possible," said Brian J. Sisko, Safeguard's President and CEO. "Since we announced our strategy, we have realized over $184 million in cash proceeds related to monetizations of our partner company interests. To date we have used those proceeds to continue to support our partner companies; to operate the business; and to retire all of our debt. We are now able to start returning value to our shareholders. At this time, our Board of Directors has determined that the most appropriate first step in this stage of the execution of our strategy is to issue a dividend. We anticipate the dividend to be characterized as a return of capital for Federal tax purposes. Whenever we have cash and cash equivalents on our balance sheet that exceeds what we believe is prudent to keep on hand to operate the business and continue to support our partner companies, our Board of Directors will authorize share repurchases and/or additional dividends. Currently, we believe $25 million is the appropriate amount to retain on our balance sheet."
The Company also announced corporate governance changes. Effective immediately, Board of Director compensation will be paid solely with Safeguard equity. Also, the size of the Board will be reduced to four from six at the Company's upcoming Annual Meeting.
Highlights
OUTLOOK
Mark A. Herndon, Safeguard's Senior Vice President and Chief Financial Officer, went on to say, "We continue to be encouraged by the performance of our portfolio, and continue to be optimistic about the overall health of our partner companies. There were no impairments during the quarter. Excluding our digital media companies, Safeguard's portfolio of partner companies is growing revenue more than 50% in aggregate. Corporate expenses for the year ended December 31, 2019 are forecasted to be at or below $8.0 million, including incremental accruals for the previously established transaction bonus plan, a substantial decline from 2018. Follow-on funding requirements for the full year are forecasted to be approximately the same as in 2018. We expect that follow-on funding requirements will decline significantly in 2020."
U.S. FEDERAL TAX TREATMENT OF THE DIVIDEND
The Company currently believes that, for U.S. federal tax purposes, the cash dividend will be treated as a return of capital to shareholders to the extent of their tax basis in Safeguard's common stock.
The ultimate tax treatment of the dividend will be based on Safeguard's current and accumulated earnings and profits for Safeguard's year ending December 31, 2019. The process of determining current and accumulated earnings and profits requires a final determination of Safeguard's financial results for the year and a review of certain other factors. The final determination of the tax treatment of the dividend will be based in part on factors that are outside of the control of Safeguard, including possible transactions involving our remaining partner companies, and which cannot be ascertained at this time. Accordingly, the expected tax treatment of the dividend is based upon currently available information and is subject to change. Safeguard expects to update information on the taxation of the dividend following the completion of 2019.
The return of capital dividend as reported on Form 8937 will be available on Safeguard's website. The Form 8937 will be updated following the determination of Safeguard's financial results for the year ended December 31, 2019 and a review of certain other factors.
The information set forth above is provided only for general use, and does not constitute a complete description of all of the U.S. federal tax consequences of the receipt of the special cash dividend or the ownership and disposition of Safeguard's common stock. Shareholders should consult their own tax advisors concerning such consequences.
AGGREGATE PARTNER COMPANY REVENUE
Aggregate partner company revenue for Safeguard's 15 remaining partner companies is projected to be between $355 million and $370 million for 2019, lower than previously forecasted. Aggregate revenue for the same partner companies was $330 million for 2018, which indicates revenue growth between 7% and 12% for the group. Excluding our digital media companies, the revenue of Safeguard's portfolio of partner companies is growing at more than 50% in aggregate year-over-year.
PARTNER COMPANY HOLDINGS AT SEPTEMBER 30, 2019
Partner Company Revenue Stages | | |||
Initial Revenue Stage · Up to $1M in revenue | Expansion Stage · $1M to $5M in revenue | Traction Stage · $5M to $10M in revenue | High Traction Stage · $10M+ in revenue |
| |||||||
| |||||||
Partner Companies | Stage | Category | Acquisition | Primary | Carrying (in millions) | | Cost (in millions) |
| | | | | | | |
Aktana, Inc. | High Traction | Healthcare | 2016 | 17.9% | $ 4.7 | | $ 11.7 |
Clutch Holdings, Inc. | High Traction | Digital Media | 2013 | 41.2% | 6.0 | | 16.6 |
Flashtalking | High Traction | Digital Media | 2018 | 10.1% | 11.0 | | 19.2 |
InfoBionic, Inc. | Traction | Healthcare | 2014 | 25.2% | - | | 22.0 |
Lumesis, Inc. | Traction | Financial Services | 2012 | 43.6% | 1.3 | | 6.3 |
MediaMath, Inc. | High Traction | Digital Media | 2009 | 13.4% | - | | 15.5 |
meQuilibrium | Traction | Healthcare | 2015 | 32.7% | 4.4 | | 13.0 |
Moxe Health Corporation+ | Expansion | Healthcare | 2016 | 32.4% | 3.4 | | 5.8 |
Prognos Health, Inc. | High Traction | Healthcare | 2011 | 28.7% | 5.2 | | 12.6 |
QuanticMind, Inc. Werbung Mehr Nachrichten zur Safeguard Scientifics Aktie kostenlos abonnieren
E-Mail-Adresse
Bitte überprüfe deine die E-Mail-Adresse.
Benachrichtigungen von ARIVA.DE (Mit der Bestellung akzeptierst du die Datenschutzhinweise) -1 Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink. Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte. |